Simon Quick Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Simon Quick Advisors's BIIB Position: Q2 2022 in Review
Simon Quick Advisors sold out of Biogen (BIIB) in Q2 2022, closing a stake of 232 shares — an estimated $49K sold.
Simon Quick Advisors first reported a position in BIIB in Q4 2016 and held it in 22 quarters. The position peaked at $170K in Q1 2018. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- Simon Quick Advisors reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
- Simon Quick Advisors sold 232 Biogen shares in Q2 2022, an estimated $49K.
- Simon Quick Advisors first reported a position in Biogen in Q4 2016 and held it in 22 quarters.
- Simon Quick Advisors's Biogen position peaked at $170K in Q1 2018.
- 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.